NMES for Achilles Tendon Rupture

Last updated: October 7, 2024
Sponsor: Penn State University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

neuromuscular electrical stimulation

Clinical Study ID

NCT04727047
STUDY00016121
  • Ages 18-65
  • All Genders

Study Summary

The majority of patients suffering an Achilles tendon rupture develop long term functional deficits in the affected leg. The goal of the proposed study is to evaluate a new rehabilitation protocol using Neuromuscular Electrical Stimulation (NMES) for reducing muscle atrophy and improving tendon properties. If proven beneficial, the proposed protocol can be easily adopted and incorporated as part of routine care for Achilles tendon rupture.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Achilles tendon rupture

Exclusion

Exclusion Criteria:

  1. Those unable to understand spoken English.

  2. Participants treated non-operatively

  3. Augmented surgical repair (i.e., use of additional tissue at the repair site)

  4. Tendon ruptures associated with the use of fluoroquinolones (Examples includeciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), norfloxacin (Noroxin), and ofloxacin (Floxin))

  5. Allergy to ultrasound gel

  6. Any other condition affecting the ability of the participant to walk or jump

  7. Any other health conditions known to impair normal healing: Diabetes, Cardiovascularconditions decreasing blood supply to the leg

  8. Those unable to consent

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: neuromuscular electrical stimulation
Phase:
Study Start date:
February 15, 2023
Estimated Completion Date:
December 31, 2024

Study Description

Achilles Tendon Ruptures (ATR) are common and permanently affect the function of the lower leg. Regardless of treatment approach the majority of patients develop long term functional deficits, which include decreased plantar flexion strength, lower heel-rise height, and altered gait patterns. It is believed that tendon lengthening and calf muscle atrophy, which develop during the first few weeks of recovery, are major factors contributing to these functional deficits. The initial development of atrophy is likely caused by reduced loading and muscle activity of the affected leg. However, long-term atrophy may be related to tendon elongation. On the other hand, tendon elongation initially rises during the first few weeks of unloading and slowly reduces, but not completely, when loading is resumed. However, atrophied calf muscles may not provide sufficient loading for optimal tendon recovery. Therefore, there seems to be vicious spiral between tendon elongation and muscle atrophy.

The objective of this study is to develop a neuromuscular electrical stimulation (NMES) rehabilitation protocol for Achilles tendon ruptures. Our preliminary data has shown that force applied to the tendon can be modulated using electrical intensity and pad placement. Therefore, NMES can produce significant contraction in the calf muscles and induce controllable, low-magnitude, cyclic loading to the tendon; which cannot be achieved with voluntary muscle contractions. This approach can potentially overcome limitations of the current rehabilitation protocols.

Connect with a study center

  • Hershey Medical Center

    Hershey, Pennsylvania 17033
    United States

    Site Not Available

  • Penn State University

    State College, Pennsylvania 16802
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.